Artwork

Content provided by CNBC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CNBC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Cisco CEO, Emergent BioSolutions CEO & J2 Global CEO

46:48
 
Share
 

Manage episode 269499519 series 2667640
Content provided by CNBC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CNBC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The Dow rallied 290 points, with the S&P 500 nearing a record close and Jim Cramer is helping investors siphon meaning from the market's moves. Then, Cisco CEO Chuck Robbins checks in after earnings to break down the company's quarter. Then, Cramer's digging into biotech play, Emergent BioSolutions, with CEO Bob Kramer to check in on the company's COVID-19 treatment. Plus, as J2 Global's stock works its way back to pre-pandemic levels, how could the company move forward after reporting better than expected earnings? CEO Vivek Shah joins Cramer to talk about the company's outlook.

  continue reading

1521 episodes

Artwork
iconShare
 
Manage episode 269499519 series 2667640
Content provided by CNBC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CNBC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The Dow rallied 290 points, with the S&P 500 nearing a record close and Jim Cramer is helping investors siphon meaning from the market's moves. Then, Cisco CEO Chuck Robbins checks in after earnings to break down the company's quarter. Then, Cramer's digging into biotech play, Emergent BioSolutions, with CEO Bob Kramer to check in on the company's COVID-19 treatment. Plus, as J2 Global's stock works its way back to pre-pandemic levels, how could the company move forward after reporting better than expected earnings? CEO Vivek Shah joins Cramer to talk about the company's outlook.

  continue reading

1521 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide